Is amyloid-β a friend or foe?

Claire S. Durrant

doi:10.1038/s41580-024-00740-0

Is amyloid-β a friend or foe?

Claire S. Durrant^*

^*Corresponding author for this work

Research output: Contribution to journal › Book/Film/Article review › peer-review

Abstract

Claire Durrant reminds us of the importance of studying the physiological roles of proteins and their aggregates to understand their roles in disease and inform therapies, discussing a 2008 paper on amyloid-β from the Arancio lab.

Original language	English
Pages (from-to)	516
Number of pages	1
Journal	Nature reviews Molecular cell biology
Volume	25
Early online date	2 May 2024
DOIs	https://doi.org/10.1038/s41580-024-00740-0
Publication status	Published - Jul 2024

Access to Document

10.1038/s41580-024-00740-0

Cite this

@article{fda576f211084200b107197f0f5d450a,

title = "Is amyloid-β a friend or foe?",

abstract = "Claire Durrant reminds us of the importance of studying the physiological roles of proteins and their aggregates to understand their roles in disease and inform therapies, discussing a 2008 paper on amyloid-β from the Arancio lab.",

author = "Durrant, \{Claire S.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2024.",

year = "2024",

month = jul,

doi = "10.1038/s41580-024-00740-0",

language = "English",

volume = "25",

pages = "516",

journal = "Nature reviews Molecular cell biology",